Medicinova, Inc. (MNOV) is a publicly traded Healthcare sector company. As of June 8, 2026, MNOV trades at $1.31 with a market cap of $64.48M and a P/E ratio of -5.72. MNOV moved +0.00% today. Year to date, MNOV is +0.00%; over the trailing twelve months it is -5.76%. Its 52-week range spans $1.13 to $2.55. Analyst consensus is buy with an average price target of $8.00. Rallies surfaces MNOV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Medicinova, Inc. (MNOV) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. MNOV moved +0.00% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $1.31 |
| Market Cap | $64.48M |
| P/E Ratio | -5.72 |
| EPS | $-0.23 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.55 |
| 52-Week Low | $1.13 |
| Volume | 18.57K |
| Avg Volume | 0 |
| Revenue (TTM) | $596.64K |
| Net Income | $-11.72M |
| Gross Margin | 0.00% |
2 analysts cover MNOV: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.00.